These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20669315)

  • 1. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia.
    Zhornitsky S; Stip E; Pampoulova T; Rizkallah E; Lipp O; Bentaleb LA; Chiasson JP; Potvin S
    Mov Disord; 2010 Oct; 25(13):2188-94. PubMed ID: 20669315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movement disorders in patients with schizophrenia and a history of substance abuse.
    Hansen LK; Nausheen B; Hart D; Kingdon D
    Hum Psychopharmacol; 2013 Mar; 28(2):192-7. PubMed ID: 23532750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.
    Zhornitsky S; Stip E; Desfossés J; Pampoulova T; Rizkallah E; Rompré PP; Bentaleb LA; Lipp O; Chiasson JP; Gendron A; Potvin S
    Front Psychiatry; 2011; 2():22. PubMed ID: 21629845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhalant abusers and psychiatric symptoms].
    Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
    Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder.
    Potvin S; Pampoulova T; Mancini-Marië A; Lipp O; Bouchard RH; Stip E
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):796-8. PubMed ID: 16705205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal symptoms in unmedicated schizophrenia.
    McCreadie RG; Srinivasan TN; Padmavati R; Thara R
    J Psychiatr Res; 2005 May; 39(3):261-6. PubMed ID: 15725424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.
    Maat A; Fouwels A; de Haan L
    Psychopharmacol Bull; 2008; 41(3):5-10. PubMed ID: 18779773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
    Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
    Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug use and dependence in schizophrenia].
    Arias Horcajadas F; Padín Calo JJ; Fernández González MA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(6):379-89. PubMed ID: 9477606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia.
    Tenback DE; van Harten PN; Slooff CJ; van Os J
    J Psychopharmacol; 2010 Jul; 24(7):1031-5. PubMed ID: 19487321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis.
    Potvin S; Blanchet P; Stip E
    Schizophr Res; 2009 Sep; 113(2-3):181-8. PubMed ID: 19608386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia.
    Chakos MH; Mayerhoff DI; Loebel AD; Alvir JM; Lieberman JA
    Psychopharmacol Bull; 1992; 28(1):81-6. PubMed ID: 1609046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.
    Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM; Franco S
    J Clin Psychiatry; 1991 Jan; 52(1):26-30. PubMed ID: 1671032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum Dickkopf-1 levels in drug-abusing psychotic patients.
    Serata D; Kotzalidis GD; Riozzi B; Storto M; Panaccione I; Romano S; Rapinesi C; Porfiri GM; Casolla B; Del Casale A; Curto M; Caloro M; Girardi N; Savoja V; Nicoletti F; Tatarelli R; Girardi P
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):239-44. PubMed ID: 22122879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.